Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 41

Trial Status

Completed4

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT03486223Phase 2Completed
Soluble Epoxide Hydrolase Inhibition and Insulin Resistance
Diabetes MellitusEndocrine System DiseasesGlucose Metabolism Disorders+2 more
PrincipalinvestigatorStart date: 2018-05-17
NCT02362308Completed
Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas
Primary Aldosteronism
PrincipalinvestigatorStart date: 2015-01-01
NCT02034435Phase 4Completed
Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism
Metabolic Syndrome
PrincipalinvestigatorStart date: 2013-10-01
NCT00732160Not ApplicableCompleted
Aldosterone and Glucose Homeostasis
Diabetes Mellitus
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Nancy J Brown, MD

Vanderbilt University Medical Center

Similar
8 trials

Shared therapeutic areas:

ObesityDiabetes MellitusEndocrine System Diseases+3 more

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)+3 more
Collaborated on 1 trial
Similarity Score64%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

ObesityMetabolic SyndromeDiabetes Mellitus+1 more
Similarity Score17%

ali ismail, lecturer

Cairo University

Related
29 trials

Shared therapeutic areas:

Metabolic SyndromeObesityDiabetes Mellitus+1 more
Similarity Score17%

Samuel Klein, MD

Washington University School of Medicine

Related
30 trials

Shared therapeutic areas:

ObesityGlucose Metabolism DisordersMetabolic Syndrome+1 more

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)+1 more
Similarity Score17%

Roman Hovorka, PhD

University of Cambridge

Related
13 trials

Shared therapeutic areas:

Diabetes MellitusEndocrine System DiseasesGlucose Metabolism Disorders

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score13%

Bruce Buckingham, MD

Stanford University

Related
24 trials

Shared therapeutic areas:

Diabetes MellitusEndocrine System DiseasesGlucose Metabolism Disorders

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score13%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

Prediabetic StateMetabolic SyndromeObesity
Similarity Score13%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Diabetes MellitusObesity
Similarity Score9%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

ObesityDiabetes Mellitus

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score9%

David s Ludwig, MD, PhD

Boston Children's Hospital

Related
17 trials

Shared therapeutic areas:

ObesityMetabolic Syndrome

Worked with same sponsors:

Brigham and Women's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT03486223Phase 2PrincipalInvestigator

Soluble Epoxide Hydrolase Inhibition and Insulin Resistance

Diabetes MellitusEndocrine System DiseasesGlucose Metabolism Disorders+2 more
Completed
NCT02362308PrincipalInvestigator

Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas

Primary Aldosteronism
Completed
NCT02034435Phase 4PrincipalInvestigator

Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism

Metabolic Syndrome
Completed
NCT00732160Not ApplicablePrincipalInvestigator

Aldosterone and Glucose Homeostasis

Diabetes Mellitus
Completed

All 4 trials loaded